Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Albireo Pharma (ALBO) shares
Learn how to easily invest in Albireo Pharma shares.
Albireo Pharma is a biotechnology business based in the US. Albireo Pharma stocks (ALBO.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $34.36 – an increase of 0.86% over the previous week. Albireo Pharma employs 90 staff and has a trailing 12-month revenue of around $10.8 million.
How to buy shares in Albireo Pharma
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ALBO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Albireo Pharma?
- Has coronavirus impacted Albireo Pharma shares?
- Albireo Pharma shares summary
- Compare share dealing platforms
- Is Albireo Pharma stock a buy or sell?
- Albireo Pharma performance over time
- Albireo Pharma's financials
- How volatile are Albireo Pharma shares?
- Does Albireo Pharma pay a dividend?
- Have Albireo Pharma shares ever split?
- Other common questions
Albireo Pharma stock price (NASDAQ:ALBO)Use our graph to track the performance of ALBO stocks over time.
Albireo Pharma shares at a glance
|Latest market close||$25.68|
|52-week range||$20.30 - $43.41|
|50-day moving average||$24.52|
|200-day moving average||$29.59|
|Wall St. target price||$76.80|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.50|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Albireo Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Albireo Pharma price performance over time
|1 week (2022-01-18)||N/A|
|1 month (2021-12-29)||9.00%|
|3 months (2021-10-25)||N/A|
|6 months (2021-07-29)||-12.38%|
|1 year (2021-01-29)||-29.97%|
|2 years (2020-01-29)||7.76%|
|3 years (2019-01-29)||13.73%|
|5 years (2017-01-27)||33.06%|
Albireo Pharma financials
|Revenue TTM||$10.8 million|
|Gross profit TTM||$8.3 million|
|Return on assets TTM||-24.89%|
|Return on equity TTM||-24.33%|
|Market capitalisation||$504.5 million|
TTM: trailing 12 months
Albireo Pharma share dividends
We're not expecting Albireo Pharma to pay a dividend over the next 12 months.
Have Albireo Pharma's shares ever split?
Albireo Pharma's shares were split on a 1:30 basis on 3 November 2016. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Albireo Pharma shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Albireo Pharma shares which in turn could have impacted Albireo Pharma's share price.
Albireo Pharma share price volatility
Over the last 12 months, Albireo Pharma's shares have ranged in value from as little as $20.3 up to $43.41. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Albireo Pharma's is 1.4009. This would suggest that Albireo Pharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Albireo Pharma overview
Albireo Pharma, Inc. , a biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. Its lead product candidate is odevixibat, an ileal bile acid transporter (IBAT) inhibitor that is in phase III clinical trial for treating patients with progressive familial intrahepatic cholestasis, as well as for treating biliary atresia, alagille syndrome, and other cholestatic liver diseases. The company is also developing Elobixibat for the treatment of chronic constipation and other functional diseases, and nonalcoholic steatohepatitis. It has a license agreement with EA Pharma Co. , Ltd. for the development and commercialization of elobixibat.
Albireo Pharma in the news
Appeals court upholds California's right to enforce its net neutrality law while the FCC remains at a standstill
Ackman takes a big stake in Netflix, excited about company's long-term prospects
What to watch today: Stock futures turn positive, reversing big overnight losses
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Samsara stock in Canada
Steps to owning and managing IOT, with 24-hour and historical pricing before you buy.
How to buy Silver Spike Investment Corp. (SSIC) stock in Canada when it goes public
Everything we know about the Silver Spike Investment Corp. IPO, plus information on how to buy in.
How to buy MOD Pizza stock in Canada when it goes public
Everything we know about the MOD Pizza IPO, plus information on how to buy in.
How to buy Modular Medical (MODD) stock in Canada when it goes public
Everything we know about the Modular Medical IPO, plus information on how to buy in.
How to buy Direct Digital Holdings (DRCT) stock in Canada when it goes public
Everything we know about the Direct Digital Holdings IPO, plus information on how to buy in.
How to buy TC BioPharm (TCBP) stock in Canada when it goes public
Everything we know about the TC BioPharm IPO, plus information on how to buy in.
How to buy Maris-Tech Ltd (MTEK) stock in Canada when it goes public
Everything we know about the Maris-Tech Ltd IPO, plus information on how to buy in.
How to buy Phoenix Motor (PEV) stock in Canada when it goes public
Everything we know about the Phoenix Motor IPO, plus information on how to buy in.
How to buy Nauticus Robotics, Inc. (KITT) stock in Canada when it goes public
Everything we know about the Nauticus Robotics, Inc. IPO, plus information on how to buy in.
What is Mogo and how can you access its new trading platform, MogoTrade? Find out in our review.